Su Jian-jia, Li Yuan, Ban Ke-chen, Qin Liu-liang, Wang Hui-yun, Yang Chun, Ou Chao, Duan Xiao-xian, Li Yong-yi, Yan Rui-qi
Guangxi Cancer Institute, Nanning 530021, China.
Zhonghua Gan Zang Bing Za Zhi. 2003 Mar;11(3):159-61.
To detect the expression and variation of p53 gene during tree shrews' hepatocarcinogenesis induced by hepatitis B virus (HBV) and aflatoxin B1 (AFB1).
Tree shrews were divided into four groups: the tree shrews were infected with HBV and fed with AFB1 in group A, only infected with HBV in group B, fed with AFB1 alone in group C, and normal control in group D. All the tree shrews were performed liver biopsy every 15 weeks. The tissues of liver and tumor were detected by immunohistochemistry and molecular biotechnologies.
(1) The incidence of hepatocellular carcinoma (HCC) in group A (66.7%) was higher than that in Group B and C (30%). HCC appearance in group A was earlier than that in group C (120.0 weeks +/-16.6 weeks vs 153.3 weeks +/-5.8 weeks, t = 3.336, P<0.01). (2) Mutated p53 protein was not found before the 75th week of the experiment in each group. (3) At the 105th week, the expression rates of mutated p53 protein were 78.6%, 60% and 71.4% in group A, B and C respectively, which were much higher than that (10%) in group D (x2 > or = 5.03, P<0.05). An abnormal band of p53 gene was detected in both group A and C. (4) The mutation points of p53 gene in liver cancer of tree shrew were at codon 275, 78 and 13. The nucleotide sequence and amino acids sequence of tree shrew's wild-type p53 showed 91.7% and 93.4% homology with those of human p53 respectively.
There is a remarkable synergistic effect between HBV and AFB1 on HCC. Mutated p53 protein is expressed before HCC occurrence, which promotes the development and progress of HCC. HBV and AFB1 may synergistically induce p53 gene mutation.
检测乙型肝炎病毒(HBV)和黄曲霉毒素B1(AFB1)诱导树鼩肝癌发生过程中p53基因的表达及变异情况。
将树鼩分为四组:A组树鼩感染HBV并喂食AFB1,B组仅感染HBV,C组仅喂食AFB1,D组为正常对照。所有树鼩每15周进行一次肝脏活检。采用免疫组织化学和分子生物技术检测肝脏和肿瘤组织。
(1)A组肝细胞癌(HCC)发生率(66.7%)高于B组和C组(30%)。A组HCC出现时间早于C组(120.0周±16.6周 vs 153.3周±5.8周,t = 3.336,P<0.01)。(2)实验第75周前各组均未发现p53蛋白突变。(3)第105周时,A组、B组和C组p53蛋白突变表达率分别为78.6%、60%和71.4%,远高于D组(10%)(χ2≥5.03,P<0.05)。A组和C组均检测到p53基因异常条带。(4)树鼩肝癌中p53基因的突变位点位于密码子275、78和13。树鼩野生型p53的核苷酸序列和氨基酸序列与人p53的同源性分别为91.7%和93.4%。
HBV与AFB1在HCC发生中存在显著协同作用。p53蛋白在HCC发生前出现突变,促进了HCC的发生发展。HBV和AFB1可能协同诱导p53基因突变。